Strong Revenue and Earnings Growth
Cigna Corporation delivered $65.5 billion in total revenue and grew adjusted earnings per share to $6.74 in the first quarter of 2025. The company also raised its full-year EPS guidance estimate to at least $29.60.
Growth in EverNorth and Cigna Healthcare
EverNorth revenues grew to $53.7 billion with a 5% increase in pretax adjusted earnings. Cigna Healthcare saw a 9% revenue growth, driven by strong rate execution and growth in select segment customers.
Success in Specialty and Care Services
EverNorth's Specialty and Care Services showed strong growth with revenue up 19% to $23.9 billion, driven by demand for specialty drugs and increased adoption of biosimilars.
Innovations in GLP-1 Programs
Cigna introduced EncircleRx, inReachRx, and InGuide to address access, affordability, clinical safety, and lifestyle changes for GLP-1 drug users, with 9 million members enrolled in EncircleRx.
Positive Client Retention and New Business Wins
Express Scripts is tracking towards mid-nineties or better retention levels, and Cigna Healthcare observed 9% customer growth year over year in the under 500 select segment.